Compare PGNY & ETV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGNY | ETV |
|---|---|---|
| Founded | 2008 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2019 | N/A |
| Metric | PGNY | ETV |
|---|---|---|
| Price | $26.24 | $14.17 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $27.44 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 252.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.75% |
| EPS Growth | ★ 2.96 | N/A |
| EPS | ★ 0.62 | N/A |
| Revenue | ★ $1,268,689,000.00 | N/A |
| Revenue This Year | $11.55 | N/A |
| Revenue Next Year | $9.52 | N/A |
| P/E Ratio | $43.27 | ★ N/A |
| Revenue Growth | ★ 11.41 | N/A |
| 52 Week Low | $13.86 | $11.05 |
| 52 Week High | $27.51 | $13.50 |
| Indicator | PGNY | ETV |
|---|---|---|
| Relative Strength Index (RSI) | 63.07 | 45.64 |
| Support Level | $23.78 | $14.20 |
| Resistance Level | $25.27 | $14.45 |
| Average True Range (ATR) | 0.86 | 0.17 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 69.55 | 25.64 |
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.